Conference Coverage
Latest News
Sep 18, 2025 | News
Effectively Managing Immunizations in the Long-Term Care Setting
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
Sep 18, 2025
Triazole Antifungal Therapy: The Clinical Utilization of Therapeutic Drug Monitoring
Sep 18, 2025
High Glucose Levels Associated With Worse Outcomes After Acute Myocardial Infarction
Sep 18, 2025
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
Sep 18, 2025
Advertisement
Shorts
0:45
Rapid Growth of 340B Raises Concerns Over Employer Drug Spending Burden
10 days ago
by
Shawn Gremminger(+1 more)
0:55
As Trusted Health Care Providers, Pharmacists Must Stay Informed
10 days ago
by
Elizabeth Vaughan, MD, MPH, RD(+1 more)
0:28
Advantages of LAIs Over Daily Oral Medications
10 days ago
by
Melissa Malinoski, PA-C(+1 more)
0:47
Madeline Camejo on Developing Future Pharmacy Leaders
10 days ago
by
Gillian McGovern, Associate Editor(+1 more)
0:50
Empowering Pharmacists for Better Health Care Access
10 days ago
by
Gillian McGovern, Associate Editor(+1 more)
0:53
Tuberculosis Is Curable and Preventable—So Why Is It Still So Deadly?
10 days ago
by
John Green(+1 more)
1:16
How Walgreens Pharmacists Are Preparing for the Fall Respiratory Season
10 days ago
by
Samantha Picking, PharmD(+1 more)
0:38
Importance of Open Discussions to Improve Vaccination Uptake
10 days ago
by
Jerome Adams, MD, MPH, FASA(+1 more)
Podcasts
Videos
Continuing Medical Education
Advertisement
All News
Advertisement
Enrollment in the Supplemental Nutrition Assistance Program or another food assistance program could help ameliorate food insecurity that contributes to long COVID.
Additionally, the FDA granted a provisional interchangeability designation to both biosimilars.
NCCN updated its small-cell lung cancer guidelines, introducing lurbinectedin for maintenance therapy and removing the chemotherapy-free interval for better treatment strategies.
Cemiplimab was also superior in improving progression-free survival, objective response rate, and duration of response in patients with non–small cell lung cancer (NSCLC).
Travelers face rising infectious disease risks, including measles, chikungunya, chagas disease, and others.
This study demonstrates the feasibility and impact of a pharmacist-led direct challenge approach to penicillin allergy delabeling in a community hospital setting.
The 2025 International Myeloma Society Annual Meeting unveils crucial updates to IMWG guidelines, enhancing response assessment and treatment strategies for multiple myeloma.
A recent study highlights the AOV dual-chamber system as a faster, safer option for RSV vaccine reconstitution, enhancing efficiency for health care providers.
Misinformation is fueling parental fears and a concerning drop in childhood vaccines.
Engagement and recognition of pharmacist expertise grows as state psychedelic bills expand.
Advertisement
Breast cancer survivors face a small but significant risk of developing secondary cancers, influenced by age, treatment, and lifestyle factors.
Promising phase 2 results for taletrectinib in ROS1+ lung cancer show significant tumor shrinkage and manageable adverse effects.
Digitoxin reduces primary composite vs placebo in HFrEF, with no statistically significant effect on individual components of all-cause mortality or first heart failure-related hospitalization.
A recent phase 3 study reveals osimertinib combined with chemotherapy offers unprecedented survival rates for patients with advanced EGFR-mutated lung cancer.
Bumetanide nasal spray provides patients with edema an alternative to burdensome oral or intravenous diuretic options.
Cutting-edge insights and expert discussions on multiple myeloma will be presented at the 2025 IMS Annual Meeting in Toronto, shaping future treatment standards.
A series of PCSK9 inhibitors were found to be tolerable and effective at reducing low-density lipoprotein cholesterol in solid organ transplant recipients.
In a recent study, machine learning demonstrated its ability to predict progression to end-stage renal disease among patients with chronic kidney disease (CKD).
Pharmacists face challenges as recent federal policy changes threaten their expanded roles in vaccination and public health, impacting patient access to care.
GLP-1 receptor agonists enhance glycemic control and weight management in youth with type 2 diabetes (T2D) and obesity; however, safety concerns persist.
World Lymphoma Day highlights the rising prevalence of lymphoma and innovative treatments, emphasizing the role of pharmacists in patient care.
Research reveals that this population may experience lower short-term mortality rates after major surgery, challenging traditional BMI guidelines.
Use of educational resources at a gastrointestinal office improved pneumococcal vaccine uptake in patients with celiac disease.
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
2
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5
